

Bayer
Diverse employees at BlueRock Therapeutics have rated Happiness, Team, and Leadership as the highest categories they have scored
Women at BlueRock Therapeutics have rated Happiness, Team, and Compensation as the highest categories they have scored
BlueRock Therapeutics employees are 70% more likely to recommend BlueRock Therapeutics as a great place to work
| 75% | Promoters |
|---|---|
| 20% | Passives |
| 5% | Detractors |
Working at BlueRock Therapeutics is rated highly by 180 employees, across various culture dimensions. BlueRock Therapeutics employees are most satisfied about CEO Rating, Compensation, and Executive Team categories, putting BlueRock Therapeutics’s culture in the Top 5% compared to similar sized companies on Comparably and in the Top 10% compared to other companies in Boston. See below in detail how working at BlueRock Therapeutics was rated by employees.
Overall Company Culture at BlueRock Therapeutics is rated A+
Last updated months ago
BlueRock Therapeutics ranks in the Top 5% of other companies on Comparably with 201-500 Employees for Overall Company Culture Score
Out of 1055 BlueRock Therapeutics employee reviews, 97% were positive. The remaining 3% were constructive reviews with the goal of helping BlueRock Therapeutics improve their work culture.
| Positive Reviews | 97% |
|---|---|
| Constructive Feedback | 3% |
What is most positive about the culture and environment at your company?Bluerock's employees care about each other and about patients. We really have a strong sense of community.
What do you like best about the leadership team?Our LT acknowledges areas for improvement and makes intentional efforts to "be better" or "do better". They have the right attitude even in difficult or challenging times.
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
BlueRock Therapeutics was founded in 2016 and its current CEO is SETH ETTENBERG, PH.D.. Since its inception 10 years ago, BlueRock Therapeutics has grown to 400 employees.
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition.
Until recently, scientists believed that mature adult cells were permanently locked into their differentiated state and unable to return to their pluripotent stem cell state. BlueRock’s focus is the natural evolution of the discoveries that shattered those old dogmas. Built on the research of some of the world’s foremost experts in induced pluripotent stem cell (iPSC) biology, BlueRock has revolutionized and scaled methods for creating authentic cell types in the areas of neurology, cardiology, and immunology.
| Headquarter | 238 Main Street Cambridge, MA 02142 United States of America |
|---|---|
| Website | www.bluerocktx.com |
| Founding Date | 2016 |
| Company Status | Private |
| Social Sites |





BlueRock Therapeutics has 400 employees. 180 employees at BlueRock Therapeutics have reviewed BlueRock Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Overall, the 180 BlueRock Therapeutics employees give their leadership a grade of A+, or Top 5% of similar size companies on Comparably. This includes specific ratings of their executive team, CEO, and manager.
Employees at BlueRock Therapeutics are extremely happy with their total compensation at BlueRock Therapeutics, which includes a combination of pay, stock and equity, and benefits.
Overall, employees at BlueRock Therapeutics are extremely happy with their team. 180 Participants grade the quality of their coworkers an A+. The majority believe the meetings at BlueRock Therapeutics are effective, and the majority look forward to interacting with their coworkers.
The majority of employees at BlueRock Therapeutics believe the environment at BlueRock Therapeutics is positive. Most Participants believe the pace of work at BlueRock Therapeutics is comfortably fast. About 69% of the employees at BlueRock Therapeutics work 8 hours or less.
Overall, the employees at BlueRock Therapeutics are extremely happy, based on their aggregated ratings of future outlook, customer perception, and their excitement going to work.


The prevailing opinion from Comparably users in Boston about their company is that it was very prepared on their first day. Boston employees concluded that their overall onboarding experience was positive. 75% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
Employees’ understanding of BlueRock Therapeutics' KPIs and OKRs is essential for its success. Out of 177 BlueRock Therapeutics employees who’ve answered, “Are your company’s goals clear and are you invested in them?” 173 have said yes.
BlueRock Therapeutics’s CEO SETH ETTENBERG, PH.D. started in this role in 2020. SETH’s approval rate is in the Top 5% of all CEOs of similar-sized companies on Comparably, and in the Top 5% compared to the CEOs of all other companies in Boston. With a high CEO score, SETH ETTENBERG, PH.D. has won the Best CEOs in 2025. In addition, SETH has garnered Best CEOs for Diversity in 2022 specifically for Diversity, making BlueRock Therapeutics’s CEO one of the top rated CEOs by diverse employees. BlueRock Therapeutics’s CEO is highly regarded especially by employees in the HR department, African American/Black employees, and employees in the Admin department. However, employees identified with Other ethnicities, employees in the R&D department, and employees with 1 to 3 Years experience have a less favorable view of the CEO and believe there is room for improvement. Compared to BlueRock Therapeutics’s competitors, SETH ETTENBERG, PH.D. ranks right above Intellia Therapeutics CEO John Leonard. Under ETTENBERG, PH.D.’s leadership, BlueRock Therapeutics employee respondents are most happy about their Compensation and the company’s Executive Team. Meetings and Gender are two areas, according to respondents, where BlueRock Therapeutics could stand to see real improvement.
The BlueRock Therapeutics Executive Team is rated an “A+” and led by CEO SETH ETTENBERG, PH.D., Chief Technology Officer Craig Beasley, and SVP, Research Stefan Irion, M.D.
SETH ETTENBERG, PH.D. CEO / President
Seth Ettenberg, PhD, is the current President and CEO of BlueRock Therapeutics. Seth served as Chief Scientific Officer... read more
Craig Beasley Chief Technology Officer
Craig Beasley is the Chief Technical Officer at BlueRock Therapeutics. Prior to joining BlueRock, Craig was the Vice... read more
Stefan Irion, M.D. SVP, Research
Stefan Irion, MD, leads the Research organization at BlueRock Therapeutics. Since joining BlueRock in 2017, Stefan has... read more
Ainslie Little, PH.D. SVP, Corporate Strategy
Ainslie Little, PhD, leads BlueRock’s strategy functions, including Business Development, Portfolio Strategy, New... read more
Beth Krewson SVP, General Counsel
Beth Krewson serves as the SVP, General Counsel of BlueRock Therapeutics.
Rebecca Milbury SVP, People & Culture
Rebecca Milbury serves as the SVP, People & Culture of BlueRock Therapeutics.
Natasha Rathee SVP, Finance
Natasha Rathee serves as the SVP, Finance of BlueRock Therapeutics.
Ahmed Enayetallah SVP, Clinical Development
Ahmed Enayetallah serves as the SVP, Clinical Development of BlueRock Therapeutics.
Diverse employees at BlueRock Therapeutics score the company 85/100 across various culture categories, placing BlueRock Therapeutics in the Top 15% of companies on Comparably with 201-500 Employees for Comparably's diversity score. The Diversity score provides insights into how diverse employees feel and rate their work experience at BlueRock Therapeutics across various culture dimensions.
In addition to a strong culture, we offer employees a generous package of benefits including: -Comprehensive medical, dental, and vision -Generous time off -Retirement savings plan -BlueWell wellness program -Equitable parental leave -Long term incentives
BlueRock Therapeutics' PTO and Vacation policy typically gives unlimited days off a year.

No Recent Jobs found for BlueRock Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Candidates By Department
All Industries | 71% | |
|---|---|---|
Business Development | 14% | |
Engineering | 14% |
Candidates By Location
Boston | 29% | |
|---|---|---|
Ozone Park | 14% | |
Other | 57% |
What is BlueRock Therapeutics address?
BlueRock Therapeutics location is at 238 Main Street
Who is the CEO of BlueRock Therapeutics?
BlueRock Therapeutics CEO is SETH ETTENBERG, PH.D., their score by employees is 89
What are the salaries in BlueRock Therapeutics
The average salary for employees in BlueRock Therapeutics is 79993$
What is BlueRock Therapeutics eNPS?
The eNPS for BlueRock Therapeutics is 70
How many employees work in BlueRock Therapeutics?
BlueRock Therapeutics has 400 employees